Literature DB >> 23724453

Development and validation of the body image scale among Thai breast cancer patients.

Dolrudee Songtish1, Prakobkiat Hirunwiwatkul.   

Abstract

OBJECTIVE: To examine the psychometric property of the Thai version of the Body Image Scale (BIS) in breast cancer patients in Thailand. MATERIAL AND
METHOD: The authors conducted a cross-culture translation of the BIS into the Thai language and administered it to 242 breast cancer patients who had surgery and had completed chemo-radiation for more than one year.
RESULTS: The present study confirmed a good reliability and validity of Thai version of BIS. The questionnaire has high internal and external consistency; Cronbach's alpha was above 0.8 and test-retest reliability was more than 0.7. Content validity was confirmed by expert opinion and cognitive interview with breast cancer patients. Construct validity was examined though factor analysis showed a single-factor solution which excludes one item from the original 10-item scale. Discriminant validity which confirmed by different score between mastectomy and breast conserving surgery group and good response prevalence also supported the clinical validity of the test.
CONCLUSION: Thai version of the BIS showed a good psychometric property and can be used as a patient-physician communication and quality of life evaluation tool after breast cancer treatment in Thai women.

Entities:  

Mesh:

Year:  2013        PMID: 23724453

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

Review 1.  Body image assessment in oncology: an update review.

Authors:  Barbara Muzzatti; Maria Antonietta Annunziata
Journal:  Support Care Cancer       Date:  2016-12-17       Impact factor: 3.603

2.  A contribution to the validation of the Italian version of the Body Image Scale (BIS).

Authors:  Maria Antonietta Annunziata; Barbara Muzzatti; Francesca Bomben; Cristiana Flaiban; Marika Piccinin; Valentina Solfrini
Journal:  BMC Cancer       Date:  2018-12-06       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.